Bigul

Kashyap Tele-Medicines Ltd - 531960 - Submission Of 'Audited Financial Results' And Auditor'S Report Thereon

Submission of 'Audited Financial Results' and Auditor's Report thereon for the quarter and year ended 31st March, 2023.
29-05-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Scheduled To Be Held On Monday, 29Th May, 2023

Kashyap Tele-Medicines Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2023 ,inter alia, to consider and approve Audited Financial Results, Statement of Assets and Liabilities, Cash Flow Statement and Audit Report thereon as per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for quarter and financial year ended 31st March, 2023
22-05-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Non-applicability of Annual Secretarial Compliance Report for the year ended 31st March, 2023
22-05-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Submission Of Certificate From Practicing Company Secretary For The Financial Year Ended 31St March, 2023 Under Regulation 40(9) & 40(10) Of SEBI (LODR) Regulations, 2015

Submission of Certificate from Practicing Company Secretary for the Financial Year ended 31st March, 2023 under Regulation 40(9) & 40(10) of SEBI (LODR) Regulations, 2015
10-04-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A

Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompanyKashyap Tele-Medicines Ltd 2CIN NO.L29110MH1995PLC085738 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY NIL 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: PARITOSH TRIVEDI Designation: COMPANY SECRETARY AND COMPLIANCE OFFICER EmailId: investor.relations@kashyaptele-medicines.com Name of the Chief Financial Officer: RAGHAV AGRAWAL Designation: DIRECTOR AND CHIEF FINANCIAL OFFICER EmailId: investor.relations@kashyaptele-medicines.com Date: 07/04/2023 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
07-04-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018 for the quarter ended 31st March, 2023
07-04-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - SUBMISSION OF COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF SEBI (LODR) REGULATIONS, 2015 FOR THE FINANCIAL YEAR ENDED 31ST MARCH, 2023

SUBMISSION OF COMPLIANCE CERTIFICATE UNDER REGULATION 7(3) OF SEBI (LODR) REGULATIONS, 2015 FOR THE FINANCIAL YEAR ENDED 31ST MARCH, 2023
07-04-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Closure of Trading Window

INTIMATION FOR CLOSURE OF TRADING WINDOW
30-03-2023
Bigul

Kashyap Tele-Medicines Ltd - 531960 - Submission Of Unaudited Financial Results Of The Company And Limited Review Report Thereon For The Third Quarter And Nine Months Ended 31St December, 2022

Submission of Unaudited Financial Results of the Company for the third quarter and nine months ended 31st December, 2022 prepared in accordance with Companies (Indian Accounting Standards) Rules, 2015 (IND-AS) alongwith the Limited Review Report as received from the Statutory Auditors thereupon as duly reviewed by the Audit Committee and subsequently approved by the Board of Directors of the Company at their respective meetings held on 10th February, 2023.
10-02-2023
Next Page
Close

Let's Open Free Demat Account